EGFR and head and neck squamous cell carcinoma: The current standard of care for unresectable recurrent or metastatic HNSCC is chemotherapy or chemotherapy plus EGFR‐targeted therapy (cetuximab) and treatment with immune checkpoint inhibitors (ICIs).2, 3